(Q44051290)

29 November 2017

Defining the risk of elective cyclosporine withdrawal in stable kidney transplant recipients (English)

1 reference

29 November 2017

1 reference

Shakeel Anjum

1

1 reference

29 November 2017

Magdalena Adeva Andany

2

1 reference

29 November 2017

Jeffrey C McClean

3

1 reference

29 November 2017

Barbara Danielson

4

1 reference

29 November 2017

Bertram L Kasiske

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

American Journal of Transplantation

29 November 2017

1 reference

29 November 2017

2

1 reference

29 November 2017

2

1 reference

29 November 2017

179-185

1 reference

Elective cyclosporine withdrawal 1 year after renal transplantation

29 November 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

Cyclosporine-associated hypertension. National High Blood Pressure Education Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

Risk for posttransplant Diabetes mellitus with current immunosuppressive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

Impact of cyclosporine withdrawal on living related renal transplants: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

The Milan clinical trial with cyclosporine in cadaveric renal transplantation. A three-year follow-up

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Cyclosporin A-associated hypertension--pathomechanisms and clinical consequences

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Early versus late acute renal allograft rejection: impact on chronic rejection.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Chronic renal allograft rejection: immunologic and nonimmunologic risk factors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Influence of DR matching in cadaveric renal transplants performed with cyclosporine. A retrospective analysis of one center

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Cyclosporine: has it made a difference between using HLA or not? A comparative study between patients with and without HLA matching

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Effects of cyclosporin on prednisolone metabolism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

Tapering or discontinuing cyclosporine for financial reasons--a single-center experience

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020210.X

7 January 2021

10.1034/J.1600-6143.2002.020210.X

Identifiers

DOI

1 reference

29 November 2017

1 reference